| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | -43.1% |
| Cost of Revenue | $567K | -57.3% |
| Gross Profit | $2.3M | -38.0% |
| R&D Expense | $0 | — |
| SG&A Expense | $4.6M | -13.0% |
| Operating Income | -$2.7M | -13.5% |
| Pre-tax Income | -$4.0M | -7.3% |
| Income Tax | $0 | — |
| Net Income | -$4.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $217K | +10.1% |
| Current Assets | $457K | -50.4% |
| Total Assets | $3.1M | -16.7% |
| Current Liabilities | $10.6M | +17.5% |
| Long-term Debt | $4.2M | +9.1% |
| Total Liabilities | $10.6M | +17.5% |
| Stockholders' Equity | -$7.0M | -55.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$484K | +19.6% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $460K | -57.4% |
| Free Cash Flow | -$484K | +19.6% |
| EPS (Basic) | -$0.02 | +33.3% |
| EPS (Diluted) | -$0.02 | +33.3% |